Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) Q1 2023 Earnings Call Transcript

Operator: Good morning, and welcome to Syros Pharmaceuticals' First Quarter 2023 Financial Results Conference Call. [Operator Instructions].

Related Keywords

United States ,Nancy Simonian ,Jason Butler ,Jason Haas ,Karen Hunady ,Conley Chee ,David Roth ,Piper Sandler ,Eric Olson ,Christian Stevens ,Mark Breidenbach ,Ted Tenthoff ,Phil Nadeau ,Corporate Communications At Syros ,Health Photo ,Pfizer ,Nasdaq ,Syros Pharmaceuticals Inc ,Syros Pharmaceuticals ,Call Transcript May ,Syros Pharmaceutical First Quarter ,Results Conference ,Investor Relations ,Corporate Communications ,Chief Executive Officer ,Chief Medical Officer ,Chief Financial ,Chief Development Officer ,Chief Scientific Officer ,Chief Commercial Officer ,Risk Factors ,Fast Track ,